K.J. Harrison & Partners Inc Raises Stake in Henry Schein, Inc. $HSIC

K.J. Harrison & Partners Inc boosted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 50.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,000 shares of the company’s stock after acquiring an additional 10,000 shares during the period. K.J. Harrison & Partners Inc’s holdings in Henry Schein were worth $2,192,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. JPMorgan Chase & Co. raised its holdings in Henry Schein by 6.5% in the first quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company’s stock worth $436,489,000 after buying an additional 390,399 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Henry Schein by 4.8% in the first quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company’s stock worth $153,480,000 after buying an additional 103,384 shares during the last quarter. Burgundy Asset Management Ltd. raised its holdings in Henry Schein by 33.9% in the first quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company’s stock worth $153,105,000 after buying an additional 566,530 shares during the last quarter. Clarkston Capital Partners LLC raised its holdings in Henry Schein by 0.4% in the first quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company’s stock worth $119,965,000 after buying an additional 7,345 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in Henry Schein by 1.0% in the first quarter. Charles Schwab Investment Management Inc. now owns 1,203,676 shares of the company’s stock worth $82,440,000 after buying an additional 11,999 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Performance

Shares of NASDAQ HSIC opened at $63.20 on Monday. The firm has a 50 day moving average of $66.19 and a 200 day moving average of $68.56. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $7.66 billion, a price-to-earnings ratio of 20.39, a price-to-earnings-growth ratio of 2.06 and a beta of 0.81. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter last year, the firm posted $1.23 earnings per share. The business’s quarterly revenue was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on HSIC. JPMorgan Chase & Co. decreased their target price on shares of Henry Schein from $80.00 to $76.00 and set an “overweight” rating for the company in a report on Thursday, August 7th. Robert W. Baird reiterated a “neutral” rating and issued a $72.00 price target (down from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. UBS Group reduced their price target on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a research note on Wednesday, August 6th. Evercore ISI upgraded shares of Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 price target for the company in a research note on Tuesday, August 26th. Finally, Leerink Partners set a $75.00 price target on shares of Henry Schein in a research note on Monday, July 14th. Five research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $76.67.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.